Laurus Labs zooms on receiving 531.77 acres of land from Government of Andhra Pradesh
Laurus Labs is currently trading at Rs. 893.15, up by 55.10 points or 6.57% from its previous closing of Rs. 838.05 on the BSE.
The scrip opened at Rs. 834.00 and has touched a high and low of Rs. 901.00 and Rs. 827.95 respectively. So far 786220 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 901.00 on 28-Jul-2025 and a 52 week low of Rs. 390.30 on 08-Aug-2024.
Last one week high and low of the scrip stood at Rs. 901.00 and Rs. 815.05 respectively. The current market cap of the company is Rs. 48244.31 crore.
The promoters holding in the company stood at 27.59%, while Institutions and Non-Institutions held 37.64% and 34.78% respectively.
Laurus Labs has received 531.77 acres of land in IP Rambilli Phase-II of Anakapalli from Government of Andhra Pradesh for establishment of Laurus Pharma Zone (LPZ) for setting up of manufacturing units for Pharma products.
The company has projected Rs 5,630 crore of investment and to provide employment to 6,350 people in three phases over a period of eight years. With this allotment, the company has secured an important component for future expansion of its business i.e., land parcel.
Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.
